Kenichi Suda
Impact in
- Oncology top 1%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 102
- Lung Cancer Diagnosis and Treatment 19
- Oncology 80
- Lung Cancer Research Studies 39
- Colorectal Cancer Treatments and Studies 17
- HER2/EGFR in Cancer Research 15
- Co-authors
- Tetsuya Mitsudomi (99 shared papers)Kenji Tomizawa (32 shared papers)Yasushi Yatabe (19 shared papers)Fred R. Hirsch (16 shared papers)Paul A. Bunn (3 shared papers)Jacinta Wiens (1 shared paper)Yoshihiko Maehara (10 shared papers)Masaki Shimoji (28 shared papers)
- Journals
- Journal of Thoracic Oncology (20 papers)Lung Cancer (18 papers)Translational Lung Cancer Research (7 papers)Cancer Research (7 papers)Clinical Lung Cancer (5 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Kenichi Suda
123 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 2.5k
- Pulmonary and Respiratory Medicine 2.8k
- Cancer Research 890
- Molecular Biology 1.7k
- Hepatology 146
Countries citing papers authored by Kenichi Suda
This map shows the geographic impact of Kenichi Suda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenichi Suda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenichi Suda more than expected).
Fields of papers citing papers by Kenichi Suda
This network shows the impact of papers produced by Kenichi Suda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenichi Suda. The network helps show where Kenichi Suda may publish in the future.
Co-authors
The 25 scholars most cited alongside Kenichi Suda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | New and emerging targeted treatments in advanced non-small-cell lung cancer Hit paper breakdown → | 2016 | 359 |
| 2 | 2011 | 223 | |
| 3 | 2017 | 215 | |
| 4 | 2010 | 170 | |
| 5 | 2009 | 170 | |
| 6 | 2010 | 168 | |
| 7 | KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments Hit paper breakdown → | 2021 | 167 |
| 8 | 2015 | 164 | |
| 9 | 2009 | 132 | |
| 10 | 2016 | 131 | |
| 11 | 2012 | 121 | |
| 12 | 2019 | 114 | |
| 13 | 2011 | 113 | |
| 14 | 2012 | 99 | |
| 15 | 2020 | 80 | |
| 16 | 2013 | 79 | |
| 17 | 2012 | 74 | |
| 18 | 2015 | 74 | |
| 19 | 2020 | 62 | |
| 20 | 1998 | 56 |
About Kenichi Suda
Kenichi Suda is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 130 papers that have together received 4.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (102 papers), Lung Cancer Research Studies (39 papers), Cancer therapeutics and mechanisms (19 papers), Lung Cancer Diagnosis and Treatment (19 papers), Colorectal Cancer Treatments and Studies (17 papers), HER2/EGFR in Cancer Research (15 papers), Cancer Genomics and Diagnostics (13 papers) and PI3K/AKT/mTOR signaling in cancer (13 papers). The work is most often cited by research in Oncology (2.5k citations), Pulmonary and Respiratory Medicine (2.8k citations), Cancer Research (890 citations), Molecular Biology (1.7k citations) and Hepatology (146 citations). Kenichi Suda has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Tetsuya Mitsudomi, Kenji Tomizawa, Yasushi Yatabe, Fred R. Hirsch, Paul A. Bunn, Jacinta Wiens, Yoshihiko Maehara, Masaki Shimoji, Hiroshi Mizuuchi and Toshiki Takemoto. Their work appears in journals such as Journal of Thoracic Oncology, Lung Cancer, Translational Lung Cancer Research, Cancer Research and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.